Mosaffarian D, Benjamin E, et al. Executive summary: heart disease and stroke statistics–2016 update: a report from the American Heart Association. Circulation. 2016;133:1483–8.

Google Scholar 

Baumgartner H. Aortic stenosis: medical and surgical management. Heart. 2005;91:1483–8.

Article  PubMed  PubMed Central  Google Scholar 

Leon M, Smith C, Mack M. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New Eng J Med. 2010;263:1597–607.

Article  Google Scholar 

Markham R, Sharma R. A review of the partner trials. Interv Cardiol Clin. 2020;9(4):461–7.

PubMed  Google Scholar 

Davlouros P, Mplani V, Koniari I, Tsigkas G. Transcatheter aortic valve replacement and stroke: a comprehensive review. J Geriatric Cardiol. 2018;15(1):95–104.

CAS  Google Scholar 

Carroll J, Mack S, Vemulapalli S, et al. TS-ACC TVT registry of transcatheter aortic valve replacement. Ann Thoracic Surg. 2021;111(2):701–22.

Article  Google Scholar 

Mack M, Leon M, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomized control trial. Lancet. 2015;9986:2477–84.

Article  Google Scholar 

Perez-Carmargo D, Travieso A, Carnero-Alcazar M, Taramasso M, Cobiella-Carnicer J, et al. Neurological outcomes of transcatheter aortic valve implantation with or without cerebral embolic protection devices: a meta-analysis. J Stroke Cerebrovasc Dis. 2022;9:106605.

Article  Google Scholar 

Kahlert P, Al-Rashid P, Dottger P. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation. 2012;126(10):1245–55.

Article  PubMed  Google Scholar 

Foley M, Hall K, Howard J, Ahmad Y, et al. Aortic valve calcium score is associated with acute stroke in transcatheter aortic valve replacement patients. J Soc Cardiovascular Angiogr Interv. 2022;4:100349.

Article  Google Scholar 

Kahlert P, Knipp S, Schlamann M, Thielmann M, Al-Rashid F, Weber M. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: diffusion weighted magnetic resonance imaging study. Circulation. 2010;121(7):870–8.

Article  PubMed  Google Scholar 

•• Kapadia S, Makkar R, Leon M, Abdel-Wahab M, Waggoner T, Massberg S, et al. Cerebral embolic protection during transcatheter aortic-valve replacement. N Engl J Med. 2022;14:1253–63. This study showed that the use of the Sentinel CEPD in TAVR did not significantly decrease the incidence of stroke.

Article  Google Scholar 

Fanning J, Walters D, Platts D, et al. Characterization of neurological injury in transcatheter aortic valve implantation: how clear is the picture? Circulation. 2014;129:504–15.

Article  PubMed  Google Scholar 

Thourani V, O’Brien S, Kelly J, et al. Development and application of a risk prediction model for in-hospital stroke after transcatheter aortic valve replacement: a report from the Society of Thoracic Surgeons/American College of Cardiology transcatheter valve therapy registry. Ann Thorac Surg. 2019;107:1097–103.

Article  PubMed  Google Scholar 

Van Mieghem N, Schipper M, Ladich E, et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation. 2013;127:2194–201.

Article  PubMed  Google Scholar 

Gasior T, Mangner N, Bijoch J, Wojakowshi W. Cerebral embolic protection system for transcatheter aortic valve replacement. J Interv Cardiology. 2018;31:891–8.

Article  Google Scholar 

Van Mieghem N, Van Gils L, Ahmad H, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. Eur Interv. 2016;12:499–507.

Google Scholar 

Haussig S, Mangener N, Dwyer M, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis. The CLEAN-TAVI randomized clinical trial. JAMA. 2016;216:592–601.

Article  Google Scholar 

• Kapadia S, Makkar R, et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol. 2017;69:367–77. This study showed that CEP devices are overall safe to use, but there was no significant difference in neurocognitive function in patients who had a CEP Devices versus those who did not at the time of TAVR implantation.

Article  PubMed  Google Scholar 

Demir O, Iannopollo G, Mangieri A, et al. The role of cerebral embolic protection devices during transcatheter aortic valve replacement. Front Cardiovasc Med. 2018;5:150.

Article  PubMed  PubMed Central  Google Scholar 

Samin M, van der Worp B, Agostoni P. TriGuardTM HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2017;89:470–7.

Article  Google Scholar 

Baumbach A, Mullen M, Brickman A, et al. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study. Eur Interv. 2015;11:75–84.

Google Scholar 

Lansky A, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuardTM HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015;36:2070–8.

Article  PubMed  Google Scholar 

Nazif T, Moses J, Sharma J, et al. Randomization of the evaluation of TriGuard cerebral embolic protection after transcatheter aortic valve replacement: REFLECT II. JACC Cardiovasc Interv. 2021;14:515–27.

Article  PubMed  Google Scholar 

Wendt D, Knipp S, et al. Intraaortic protection from embolization in patients undergoing transaortic transcatheter aortic calve implatation. Ann Thorac Surg. 2015;100:686–91.

Article  PubMed  Google Scholar 

Rodes-Cabau J, Kahlert P, Neumann F, Schymik G, Webb J, Amarenco P. Feasibility and exploratory efficacy evaluation of Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve repalcement: the PROTAVI-C pilot study. JACC Cardiovasc Interv. 2014;7(10):1146–55.

Article  PubMed  Google Scholar 

Russell S. Total embolic protection: the emboliner embolic protection catheter, early clinical results. Presented at Transcatheter Cardiovascular Therapeutics, San Francisco, California; 2019.

Google Scholar 

Kolte D, Nazir S, Butala N, Bhatt D, Elmariah S. Trends in cerebral embolic protection device use and association with stroke following transcatheter aortic valve implantation. Am J Cardiol. 2021;152:106–12.

Article  PubMed  Google Scholar 

Teitelbaum M, Kotronias R, Sposato L, Bagur R. Cerebral embolic protection in TAVI: friend or foe. Interv Cardiol. 2019;14:22–5.

Article  PubMed  PubMed Central  Google Scholar 

Bagur R, Solo K, Alghofaili S, et al. Cerebral embolic protection devices during transcatheter aortic valve implantation. Systematic review and meta-analysis. Stroke. 2017;48:1306–15.

Article  PubMed  Google Scholar 

Rodes-Cabau J, Dumont E, Boone R, Larose E, Bagur R, Guvitch R. Cerebral ebolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57(1):18–28.

Article  PubMed  Google Scholar 

Ghanem A, Dorner J, Schulze-Hagen L, Muller A, Wilsing M, Sinning J, et al. Subacute cubclinical brain infarctions after transcatheter aortic valve implantation negatively impact cognitive function in long-term follow-up. PLoS ONE. 2017;12(1):e0168852.

Article  PubMed  PubMed Central  Google Scholar 

Uddin A, Fairbairn T, Igra M, Djoukhader I. Consequences of cerebral embolism after transcatheteri aortic valve implantation compared with contemporary surgical valve replacement: effect on health-related quality of life. Circ Cardiovasc Interv. 2015;8(3):e001913.

Article  PubMed  Google Scholar 

Agrawal A, Isogai T, Shekhar S. Kapadia SR (2023) Cerebral embolic protection devices. US Cardiol Rev. 2023;17:e02.

Article  Google Scholar